Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-25-000181
Filing Date
2025-08-07
Accepted
2025-08-06 17:50:51
Documents
97
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ebs-20250630.htm   iXBRL 10-Q 1911526
2 EX-10.1 av7909mod19redacted.htm EX-10.1 6970
3 EX-31.1 a311-papacert063025.htm EX-31.1 8501
4 EX-31.2 a312-lindahlcert063025.htm EX-31.2 8561
5 EX-32.1 a321-papacert063025.htm EX-32.1 3437
6 EX-32.2 a322-lindahlcert063025.htm EX-32.2 3387
12 av7909mod19redacted001.jpg GRAPHIC 231590
13 av7909mod19redacted002.jpg GRAPHIC 101937
14 av7909mod19redacted003.jpg GRAPHIC 81857
15 ebs-20250630_g1.jpg GRAPHIC 75656
  Complete submission text file 0001367644-25-000181.txt   10231124

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20250630.xsd EX-101.SCH 61203
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20250630_cal.xml EX-101.CAL 82635
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20250630_def.xml EX-101.DEF 332153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20250630_lab.xml EX-101.LAB 737780
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20250630_pre.xml EX-101.PRE 551927
100 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20250630_htm.xml XML 1514188
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 251190865
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)